CD274 and neoplasm: Programmed death ligand-1 (PD-L1), encoded by the CD274 gene, is an immune checkpoint inhibitor that, when expressed on the surface of tumor or on antigen presenting cells (APC), binds to programmed death-1 (PD-1) on T lymphocytes, inhibiting their immune function.